Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Miragen Therapeutics Inc (MGEN)

   0 (0%) 12-31 19:00
Open: Pre. Close:
High: Low:
Volume: Market Cap: 0M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 18.414 - 18.488 18.488 - 18.559
Low: 17.32 - 17.4 17.4 - 17.477
Close: 18.257 - 18.387 18.387 - 18.511

Technical analysis

as of: 2021-03-26 8:18:43 PM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 22.18     One year: 25.91
Support: Support1: 16.31    Support2: 14.65
Resistance: Resistance1: 18.99    Resistance2: 22.18
Pivot: 17.42
Moving Average: MA(5): 18.10     MA(20): 17.39
MA(100): 18.28     MA(250): 14.76
MACD: MACD(12,26): -0.06     Signal(9): -0.27
Stochastic oscillator: %K(14,3): 81.45     %D(3): 80.73
RSI: RSI(14): 53.10
52-week: High: 25.67  Low: 5.53  Change(%): 208.0
Average Vol(K): 3-Month: 5865  10-Days: 2011

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
MGEN has closed below upper band by 24.9%. Bollinger Bands are 47.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to MGEN's normal range. The bands have been in this narrow range for 21 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Fri, 18 Jun 2021
Miragen Therapeutics - Consensus Indicates Potential 111.1% Upside - DirectorsTalk Interviews

Tue, 19 Jan 2021
MiRagen rebrands to Veridian months after acquisition, names new CEO - Boulder Daily Camera

Tue, 19 Jan 2021
miRagen Therapeutics Announces Company Name Change to - GlobeNewswire

Tue, 08 Dec 2020
Miragen: Viridian Therapeutics Acquisition Offers Good Speculative Entry Opportunity - Seeking Alpha

Thu, 12 Nov 2020
MiRagen reports loss, effects reverse stock split - Boulder Daily Camera

Tue, 10 Nov 2020
miRagen Reports Third Quarter 2020 Financial Results and - GlobeNewswire

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Neutral Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Outperform
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Shares Out. (M) 4
Shares Float (M) 2
% Held by Insiders 0.17
% Held by Institutions 55.33
Shares Short (K) 162
Shares Short P. Month (K) 152

Stock Financials

EPS -9.670
EPS Est This Year -1.520
EPS Est Next Year -1.660
Book Value (p.s.) 5.530
Profit Margin
Operating Margin -1469.19
Return on Assets (ttm) -48.1
Return on Equity (ttm) -136.1
Qtrly Rev. Growth
Gross Profit (p.s.) -7.322
Sales Per Share 0.481
EBITDA (p.s.) -6.982
Qtrly Earnings Growth
Operating Cash Flow (M) -28
Levered Free Cash Flow (M) -16

Stock Valuations

PE Ratio -1.90
PEG Ratio
Price to Book value 3.33
Price to Sales 38.25
Price to Cash Flow -2.55

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.